Bisphosphonates are generally used to treat osteoporosis and decrease the risk of femoral neck and vertebral fractures in patients with osteoporosis. Recently, it has been suggested that long-term bisphosphonate use can lead to decreased bone remodeling and an increased risk of atypical fractures. Atypical fractures often occur in the femur. The purpose of the present report is to describe a rare case of simultaneous, bilateral, atypical femoral fractures. An 80-year-old female was walking when she sustained bilateral femoral fractures that were diagnosed as atypical. The patient had received bisphosphonate treatment over the prior nine years.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636182 | PMC |
http://dx.doi.org/10.7759/cureus.19177 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!